Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis

Blood

Volumn 100, Issue 13, 2002, Pages 4495-4501

  Lamouille, Samy ^a   Mallet, Christine ^a   Felge, Jean Jacques ^a   Bailly, Sabine ^a  

^a CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 1; BETA ACTIN; COMPLEMENTARY DNA; PAXILLIN; TRANSFORMING GROWTH FACTOR BETA; ZYXIN;

ANGIOGENESIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DERMIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG; MICROVASCULATURE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; UMBILICAL VEIN;

EID: 0037114702     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.13.4495     Document Type: Article

References (26)

1. Panchenko MP, Williams MC, Brody JS, Yu Q. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am J Physiol. 1996;270:L547-558.
2. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189-195.
3. Azuma H. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest. 2000;47:81-90.
4. Oh SP, Seki T, Goss KA, et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A. 2000;97:2626-2631.
5. Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet. 2000;26:328-331.
6. Roman BL, Pham VN, Lawson ND, et al. Disruption of acvr11 increases endothelial cell number in zebrafish cranial vessels. Development. 2002;129:3009-3019.
7. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 1993;75:671-680.
8. Carcamo J, Weis FM, Ventura F, et al. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol. 1994;14:3810-3821.
9. ten Dijke P, Yamashita H, Ichijo H, et al. Characterization of type I receptors for transforming growth factor-beta and activin. Science. 1994;264:101-104.
10. De Winter JP, De Vries CJ, Van Achterberg TA, et al. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I receptors. Exp Cell Res. 1996;224:323-334.
11. Abdalla SA, Pece-Barbara N, Vera S, et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet. 2000;9:1227-1237.
12. Lux A, Attisano L, Marchuk DA. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem. 1999;274:9984-9992.
13. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL. Specific activation of Smadl signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem. 1998;273:25628-25636.
14. Chen YG, Massague J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem. 1999;274:3672-3677.
15. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
16. Fujii M, Takeda K, Imamura T, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell. 1999;10:3801-3813.
17. Wu X, Robinson CE, Fong HW, et al. Cloning and characterization of the murine activin receptor like kinase-1 (ALK-1) homolog. Biochem Biophys Res Commun. 1995;216:78-83.
18. Beckerle MC. Zyxin: Zinc fingers at sites of cell adhesion. Bioessays. 1997;19:949-957.
19. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol. 1999;144:1235-1244.
20. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12:27-36.
21. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. The activity of guanine exchange factor net1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem. 2001;276:15362-15368.
22. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295-309.
23. Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 1997;94:11514-11519.
24. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem. 1988;263:7741-7746.
25. Morgan TE, Rozovsky I, Sarkar DK, et al. Transforming growth factor-beta 1 induces transforming growth factor- beta 1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. Neuroscience. 2000;101:313-321.
26. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001;345:325-334.